March 17, 2025 10:02 AM EDT
Pharma
FDA+

Post-Hoc: Kennedy's an­ti-vac­cine ac­tions should­n't sur­prise any­one

Max Bayer

Pharma Reporter

At the end of Robert F. Kennedy Jr.’s con­fir­ma­tion hear­ing, Sen­ate HELP Com­mit­tee Chair­man Bill Cas­sidy (R-LA) raised a rhetor­i­cal ques­tion at the heart of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

As­traZeneca to buy cell ther­a­py start­up for $425M up­front

As­traZeneca spot­lights first-in-hu­man da­ta for B7-H4-tar­get­ing ADC in en­dome­tri­al can­cer

George Church spin­out de­vel­op­ing ge­nom­i­cal­ly re­cod­ed or­gan­isms cuts most em­ploy­ees

HC Bio­science, a tR­NA biotech backed by ARCH and Take­da, shuts down

In­cyte's stock sinks as piv­otal skin dis­ease da­ta dis­ap­point

Lil­ly-backed UK biotech rais­es $72M to ad­vance its an­ti­body ap­proach

A service from the Financial Times